|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Abbott Laboratories, of Abbott Park, Ill., said the European Medicines Evaluation Agency granted a positive opinion on Humira (adalimumab), or D2E7, for the treatment of adult rheumatoid arthritis. Abbott said Humira will become the first human monoclonal antibody approved in Europe for RA, and the first tumor necrosis factor alpha antagonist approved with an indication for use with methotrexate or as monotherapy. Humira works by blocking TNF-alpha.
o Advanced Life Sciences Inc., of Woodbridge, Ill., licensed proteomics-based technology from the Argonne National Laboratory in Argonne, Ill. Included is a compound called ALS-499, which has shown inhibitory ...
Related newspaper, magazine, and journal articles:
|
|
Article: BIOWORLD TODAY READER SURVEY.
BIOWORLD Today;
January 26, 1999 ;
396 words
... ... The results will be used to improve BioWorld Today. Name: Title: Company: Phone ... provided. 1. What is your opinion of BioWorld Today? How has the newsletter helped you ... 3. What publications, other than BioWorld Today, do you turn to for biotechnology ...
|
|